Mr. Patrick P. Fourteau, CEO of Sciele Pharma, Inc. (SCRX),
Ring The NASDAQ Stock Market Closing Bell

Monday, June 19, 2006
at NASDAQ's MarketSite
in New York City.
Mr. Patrick P. Fourteau, CEO ofSciele Pharma, Inc. (SCRX)

Mr. Patrick P. Fourteau, CEO of Sciele Pharma, Inc. (SCRX), preside over the closing bell.

Sciele Pharma, Inc. (SCRX) is a specialty pharmaceutical company that markets, develops and sells brand name prescription products for the primary service of cardiology and women's health. Sciele Pharma, Inc. (SCRX) has a portfolio that includes 15 branded products, of which eight are actively promoted to high prescribing physicians through its recently expanded nationwide sales force of approximately 525 sales representatives.

Click for larger pictures of the NASDAQ MarketSite. Additional Photographs for 6/19/2006 Download Hi-Res Quality Photo of this NASDAQ Market Close - Pictured:Mr. Patrick P. Fourteau, CEO of Sciele Pharma, Inc. (SCRX), rings the Closing Bell These photos are Copyright 2006, The Nasdaq Stock Market Inc. and available for re-publication by the news media only. Any commercial use is strictly prohibited without the prior written consent of The Nasdaq Stock Market Inc. © Copyright 2006, The NASDAQ Stock Market, Inc. Reprinted with the permission of The Nasdaq Stock Market, Inc.